| Literature DB >> 31996813 |
Hitomi Hayabuchi1, Rieko Morita2, Masanori Ohta2, Akiko Nanri2, Hideki Matsumoto3, Shoji Fujitani3, Shintaro Yoshida3, Sadayoshi Ito4,5, Atsushi Sakima6, Hiroyuki Takase7, Miho Kusaka8, Takuya Tsuchihashi9.
Abstract
Sodium reduction is an important public health goal. Individual and population approaches are necessary for reducing the sodium content of processed foods and meals. The aim of the present study is to affirm the effect of monosodium L-glutamate (MSG), an umami substance, on the saltiness or palatability of low-salt solutions and to explore the preferred salt concentration in soup. Five hundred and eighty-four healthy participants from nineteen regions in Japan tasted 0.3, 0.6, and 0.9% NaCl solutions with or without 0.3% MSG. Evaluations of saltiness and palatability for each solution were conducted using a visual analog scale in a double-blinded randomized manner. Saltiness gradually increased depending on the concentration of NaCl. The saltiness of the 0.3% NaCl solution with MSG was rated significantly higher than that without MSG. The palatability ratings were higher for the solutions with MSG than for those without MSG for all NaCl concentrations. In particular, the palatability rating of the 0.3% NaCl solution with MSG was twice as high as that without MSG and was significantly higher than that of the other five test solutions. Furthermore, these results were observed to be approximately the same, irrespective of sex, age, region, etc. Salt reduction is believed to result in a loss of palatability. However, our results suggest that umami can compensate for the loss of palatability caused by salt reduction and that the addition of an appropriate amount of an umami substance can facilitate salt reduction from 0.9 to 0.3% without sacrificing palatability.Entities:
Keywords: Glutamate; Palatability; Randomized blind experiment; Sodium reduction; Umami
Year: 2020 PMID: 31996813 PMCID: PMC8075858 DOI: 10.1038/s41440-020-0397-1
Source DB: PubMed Journal: Hypertens Res ISSN: 0916-9636 Impact factor: 3.872
Fig. 1Flow chart of the analyzed participants
Characteristics of the study participants
| Characteristics | Male | Female | All |
|---|---|---|---|
| All | 69 (100) | 515 (100) | 584 (100) |
| Age groupa | |||
| 19–29 | 6 (8.7) | 251 (48.9) | 257 (44.0) |
| 30–59 | 17 (24.6) | 55 (10.7) | 72 (12.3) |
| 60–69 | 21 (30.4) | 79 (15.4) | 100 (17.1) |
| >70 | 25 (36.2) | 128 (25.0) | 153 (26.2) |
| Smokinga | |||
| Smoker | 7 (10.1) | 7 (1.4) | 14 (2.4) |
| Past smoker | 20 (29.0) | 8 (1.6) | 28 (4.8) |
| Never smoker | 40 (58.0) | 499 (96.9) | 539 (92.3) |
| Fasting timea | |||
| ≤2 h | 24 (34.8) | 105 (20.4) | 129 (22.1) |
| >2 h | 45 (65.2) | 408 (79.2) | 453 (77.6) |
| Medicinea | |||
| With medication | 36 (52.2) | 163 (31.7) | 199 (34.1) |
| No medication | 31 (44.9) | 351 (68.2) | 382 (65.4) |
| Areab | |||
| Tohoku | 9 (13.0) | 59 (11.5) | 68 (11.6) |
| Kanto–Tokai | 14 (20.3) | 130 (25.2) | 144 (24.7) |
| Kinki–Chugoku | 15 (21.7) | 100 (19.4) | 115 (19.7) |
| North Kyushu | 30 (43.5) | 157 (30.5) | 187 (32.0) |
| South Kyushu | 1 (1.4) | 69 (13.4) | 70 (12.0) |
aData exclude the participants who did not answer the questionnaire
bTohoku includes Aomori and Miyagi; Kanto–Tokai includes Chiba, Saitama, Kanagawa, Tokyo and two areas in Shizuoka; Kinki–Chugoku includes two areas each in Nara and Hiroshima; North Kyushu includes Kitakyushu, Munakata, two areas in Fukuoka and Nagasaki; and South Kyushu includes Kagoshima and Okinawa
Fig. 2Mean and SE of saltiness (A) and palatability (B) VAS ratings obtained from the sensory evaluation. The VAS ratings of saltiness and palatability of six samples containing three different concentrations of NaCl (0.3, 0.6, and 0.9%) with or without added MSG (0.3%) among 584 participants. The significant differences between each column are indicated by alphabetic superscripts. A column is significantly different from others that do not have the same superscript according to Tukey’s test (P < 0.05). An asterisk represents P for repeated measures ANOVA
Mean and SE of saltiness VAS ratings by age, sex, smoking, fasting time, and medication
| 0.3% NaCl | 0.6% NaCl | 0.9% NaCl | ||||||
|---|---|---|---|---|---|---|---|---|
| N | −MSG | +MSG | −MSG | +MSG | −MSG | +MSG | ||
| All | 584 | 23.5 ± 0.6a | 39.1 ± 0.7b | 55.8 ± 0.7c | 58.2 ± 0.7d | 73.8 ± 0.6e | 72.3 ± 0.7e | <0.0001 |
| Sex | ||||||||
| Male | 69 | 22.1 ± 1.7a | 34.6 ± 2.0b | 49.6 ± 2.3c | 52.9 ± 2.0c | 70.0 ± 1.8d | 67.2 ± 1.9d | <0.0001 |
| Female | 515 | 23.7 ± 0.7a | 39.7 ± 0.8b | 56.6 ± 0.7c | 58.9 ± 0.7d | 74.3 ± 0.7e | 73.0 ± 0.7e | <0.0001 |
| Age group (year) | ||||||||
| 19–29 | 257 | 24.0 ± 0.9a | 45.3 ± 1.0b | 61.2 ± 0.9c | 65.6 ± 0.8d | 79.0 ± 0.8e | 79.5 ± 0.7e | <0.0001 |
| 30–59 | 72 | 21.4 ± 1.8a | 35.0 ± 2.1b | 51.2 ± 2.2c | 56.7 ± 2.0c | 71.2 ± 2.1d | 69.1 ± 2.2d | <0.0001 |
| 60–69 | 100 | 21.8 ± 1.5a | 34.2 ± 1.7b | 52.7 ± 1.7c | 52.5 ± 1.7c | 69.8 ± 1.5d | 66.8 ± 1.5d | <0.0001 |
| >70 | 153 | 25.1 ± 1.2a | 33.7 ± 1.3b | 51.0 ± 1.4c | 50.4 ± 1.5c | 69.0 ± 1.3d | 65.6 ± 1.4d | <0.0001 |
| Smoking | ||||||||
| Smoker | 14 | 19.6 ± 4.2a | 36.8 ± 4.2b | 54.6 ± 3.9c | 51.0 ± 4.9c | 78.4 ± 4.4d | 70.9 ± 4.9d | <0.0001 |
| Past smoke | 28 | 24.8 ± 3.1a | 34.5 ± 3.0b | 49.2 ± 3.4c | 55.1 ± 3.3c | 72.3 ± 2.3d | 65.6 ± 3.2d | <0.0001 |
| Never smoker | 539 | 23.6 ± 0.6a | 39.4 ± 0.7b | 56.2 ± 0.7c | 58.6 ± 0.7d | 73.8 ± 0.7e | 72.7 ± 0.7e | <0.0001 |
| Fasting time | ||||||||
| ≤2 h | 129 | 25.1 ± 1.4a | 35.9 ± 1.5b | 52.0 ± 1.7c | 53.5 ± 1.5c | 70.2 ± 1.5d | 67.7 ± 1.4d | <0.0001 |
| >2 h | 453 | 23.0 ± 0.7a | 39.9 ± 0.8b | 56.8 ± 0.8c | 59.6 ± 0.8d | 74.8 ± 0.7e | 73.7 ± 0.7e | <0.0001 |
| Medicine | ||||||||
| With medication | 199 | 24.2 ± 1.1a | 36.1 ± 1.2b | 53.6 ± 1.2c | 54.2 ± 1.3c | 70.6 ± 1.1d | 68.3 ± 1.1d | <0.0001 |
| No medication | 382 | 23.3 ± 0.8a | 40.8 ± 0.9b | 57.0 ± 0.9c | 60.5 ± 0.8d | 75.5 ± 0.8e | 74.6 ± 0.8e | <0.0001 |
The significant differences between each rating score are indicated by alphabetic superscripts. A rating score is significantly different from others that do not have the same superscript letter according to Tukey’s test (P < 0.05)
*P for repeated measures ANOVA
Mean and SE of palatability VAS ratings by age, sex, smoking, fasting time, and medication
| 0.3% NaCl | 0.6% NaCl | 0.9% NaCl | ||||||
|---|---|---|---|---|---|---|---|---|
| N | −MSG | +MSG | −MSG | +MSG | −MSG | +MSG | ||
| All | 584 | 30.7 ± 0.8a | 60.6 ± 0.9b | 44.8 ± 0.7c | 57.4 ± 0.7d | 40.7 ± 0.7e | 51.6 ± 0.8f | <0.0001 |
| Sex | ||||||||
| Male | 69 | 28.9 ± 2.2a | 56.2 ± 2.6b | 39.7 ± 1.9c | 54.1 ± 1.7b | 41.6 ± 2.0c | 50.3 ± 2.3b | <0.0001 |
| Female | 515 | 30.9 ± 0.8a | 61.2 ± 1.0b | 45.4 ± 0.7c | 57.8 ± 0.8d | 40.5 ± 0.8e | 51.7 ± 0.9f | <0.0001 |
| Age group (year) | ||||||||
| 19–29 | 257 | 32.1 ± 1.2a | 61.6 ± 1.4b | 47.4 ± 1.0c | 58.8 ± 1.1b | 42.4 ± 1.1d | 51.7 ± 1.3c | <0.0001 |
| 30–59 | 72 | 25.9 ± 1.8a | 65.5 ± 2.7b | 43.5 ± 2.3c,d | 57.1 ± 2.2e | 38.9 ± 2.1c | 51.5 ± 2.5d,e | <0.0001 |
| 60–69 | 100 | 27.8 ± 1.8a | 59.5 ± 2.0b | 42.3 ± 1.6c | 55.1 ± 1.7b,d | 39.9 ± 1.7c | 51.5 ± 1.8d | <0.0001 |
| >70 | 153 | 32.6 ± 1.5a | 57.8 ± 1.8b | 42.6 ± 1.4c | 56.6 ± 1.4b,d | 39.1 ± 1.6c | 51.6 ± 1.5d | <0.0001 |
| Smoking | ||||||||
| Smoker | 14 | 33.3 ± 5.9a | 63.4 ± 4.5b | 49.4 ± 5.4 | 62.0 ± 4.0b | 40.4 ± 7.1a,c | 55.3 ± 3.9b,c | 0.0002 |
| Past smoker | 28 | 29.3 ± 3.5a | 54.3 ± 4.2b | 39.2 ± 2.8a,c | 53.8 ± 3.2b | 38.9 ± 2.9a,c | 50.6 ± 3.9b,c | <0.0001 |
| Never smoker | 539 | 30.6 ± 0.8a | 60.9 ± 0.9b | 44.9 ± 0.7c | 57.5 ± 0.8d | 40.8 ± 0.8e | 51.5 ± 0.9f | <0.0001 |
| Fasting time | ||||||||
| ≤2 h | 129 | 33.3 ± 1.7a | 59.7 ± 2.0b | 43.1 ± 1.7c | 57.3 ± 1.5b | 37.5 ± 1.6c | 49.8 ± 1.7d | <0.0001 |
| >2 h | 453 | 29.8 ± 0.8a | 60.9 ± 1.0b | 45.2 ± 0.8c | 57.4 ± 0.8d | 41.5 ± 0.8e | 52.0 ± 0.9f | <0.0001 |
| Medicine | ||||||||
| With medication | 199 | 31.1 ± 1.3a | 56.7 ± 1.5b | 43.5 ± 1.2c | 55.0 ± 1.2b,d | 41.2 ± 1.3c | 50.5 ± 1.3d | <0.0001 |
| No medication | 382 | 30.6 ± 0.9a | 62.9 ± 1.1b | 45.5 ± 0.9c | 58.7 ± 0.9d | 40.4 ± 0.9e | 52.1 ± 1.1f | <0.0001 |
The significant differences between each rating score are indicated by alphabetic superscripts. A rating score is significantly different from others that have different superscript letters according to Tukey’s test (P < 0.05). A rating score without any alphabetic superscripts is not significantly different from any other score
*P for repeated-measures ANOVA
Sodium (Na) content of the six test solutions
| NaCl (g/100 mL) | 0.3 | 0.6 | 0.9 | |||
|---|---|---|---|---|---|---|
| 0.3% MSG | – | + | – | + | – | + |
| Na (g/100 mL) | 0.118 | 0.155 | 0.236 | 0.273 | 0.354 | 0.391 |
| Na (100%: 0.9% NaCl + 0.3% MSG)a | 30.2 | 39.6 | 60.4 | 69.8 | 90.5 | 100 |
aAssuming sodium content to be 100% in the sample containing 0.9% NaCl with 0.3% MSG, the amounts of sodium in the other samples are indicated